Early growth response-1 is a new substrate of the GSK3β-FBXW7 axis

Lu Yin1, Jiagui Zhang1, Yi Sun2

  • 1Cancer Institute of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310009, China; Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou 310029, China.

Neoplasia (New York, N.Y.)
|October 14, 2022
PubMed

Insights

The study identifies FBXW7 as a novel E3 ligase for EGR1, a key factor in cell proliferation and tumor growth. This discovery reveals a new regulatory axis involving GSK3β and FBXW7 that impacts cancer cell growth.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Cell Signaling

Background:

  • Early growth response 1 (EGR1) is a transcription factor regulating cell proliferation and tumor progression.
  • The precise regulation of EGR1 by Cullin-RING ligases (CRLs) has not been fully elucidated.
  • Understanding EGR1 regulation is crucial for developing targeted cancer therapies.

Purpose of the Study:

  • To investigate the role of CRLs in EGR1 regulation.
  • To identify the specific E3 ligase responsible for EGR1 degradation.
  • To elucidate the functional consequences of EGR1 regulation in cancer cells.

Main Methods:

  • Utilized MLN4924, a neddylation inhibitor, to assess EGR1 stability.
  • Employed siRNA-mediated knockdown and overexpression of FBXW7 to study its effect on EGR1 levels.
  • Investigated the interaction between FBXW7 and EGR1 using binding assays and mutant analysis.
  • Assessed the role of GSK3β kinase in the FBXW7-EGR1 regulatory axis.
  • Evaluated the impact of EGR1 and FBXW7 modulation on cancer cell growth.

Main Results:

  • Identified SCFFBXW7 (CRL1) as a novel E3 ligase for EGR1.
  • Demonstrated that FBXW7 binds to EGR1 via a specific degron, and cancer-derived FBXW7 mutants exhibit reduced binding.
  • Showed that FBXW7 knockdown leads to EGR1 accumulation and extended protein half-life, while FBXW7 overexpression promotes EGR1 polyubiquitylation.
  • Established that GSK3β kinase is essential for FBXW7-mediated EGR1 degradation.
  • Found that hypoxia enhances FBXW7-EGR1 interaction and subsequent EGR1 degradation.
  • Confirmed that EGR1 knockdown suppresses cancer cell growth, and FBXW7 knockdown-induced growth is partially dependent on EGR1.

Conclusions:

  • EGR1 is a novel substrate of the GSK3β-FBXW7 regulatory axis.
  • The FBXW7-EGR1 pathway plays a significant role in coordinating cancer cell growth.
  • Targeting the FBXW7-EGR1 axis presents a potential therapeutic strategy for cancer treatment.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.1K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K